[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.5.76. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Viewpoint
January 2015

Bundling Informed Consent and Advance Care Planning in Chronic Cardiovascular DiseaseWe Need to Talk

Author Affiliations
  • 1Hospital of the University of Pennsylvania, Perelman School of Medicine, Philadelphia
  • 2Saint Louis University School of Medicine, St Louis, Missouri
  • 3Oregon Health Sciences University, Portland
  • 4Veterans Affairs Medical Center, Portland, Oregon
JAMA Intern Med. 2015;175(1):5-6. doi:10.1001/jamainternmed.2014.6219

Modern cardiovascular therapies offer unprecedented opportunities to improve survival and quality of life. Cardiovascular morbidity and mortality have significantly declined, owing in a large part to preventive therapies and technological advances such as coronary revascularization, implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs). Newer therapies like transcatheter aortic valve replacement hold great promise. Nonetheless, cardiovascular disease remains a leading cause of death.

First Page Preview View Large
First page PDF preview
First page PDF preview
×